Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Triethylenethiophosphoramide |
EINECS | 200-135-7 |
CAS No. | 52-24-4 | Density | 1.5 g/cm3 |
PSA | 50.93000 | LogP | 0.62200 |
Solubility | water: 19 g/100 mL (25 °C) | Melting Point |
54-57 °C |
Formula | C6H12N3PS | Boiling Point | 270.2 °C at 760 mmHg |
Molecular Weight | 189.221 | Flash Point | 117.2 °C |
Transport Information | UN 2811 6.1/PG 2 | Appearance | white crystals or powder |
Safety | 53-22-26-36/37/39-45-36/37-28 | Risk Codes | 45-46-28 |
Molecular Structure | Hazard Symbols | T+ | |
Synonyms |
Phosphinesulfide, tris(1-aziridinyl)- (7CI,8CI);1,1',1''-Phosphinothioylidynetrisaziridine;AI 3-24916;CBC 806495;Girostan;N,N',N''-Triethylenethiophosphoramide;N,N',N''-Triethylenethiophosphortriamide;NCI C01649;NSC 6396;Oncotepa;Oncothio-tepa;Oncotiotepa;Phosphorothioic acid triethylenetriamide;Phosphorothioic triamide, N,N',N''-tri-1,2-ethanediyl-;SK 6882;STEPA;TESPA;TSPA;Tespamin;Tespamine;Thio-Tep;Thio-Tepa S;Thiofozil;Thiophosphamide;Thiophosphoramide, N,N',N''-tri-1,2-ethanediyl-;Thioplex;Thiotef;Thiotepa;Tio-TEF;Tiofosfamid;Tiofosyl;Tiofozil;Triethylenethiophosphoramide;Tris(1-aziridinyl)phosphine sulfide; |
Article Data | 10 |
Conditions | Yield |
---|---|
With trichlorothiophosphine at 16.5℃; for 0.533333h; Temperature; | 90.7% |
With trichlorothiophosphine; triethylamine; benzene |
Thiotepa
N,N',N''-tris(β-mercaptoethyl)triamidothiophosphate
Conditions | Yield |
---|---|
With hydrogenchloride; lithium thiophosphate powder In water; N,N-dimethyl-formamide at 25℃; | 94% |
Thiotepa
C6H15N3O9P4S4(6-)*6Li(1+)
Conditions | Yield |
---|---|
With hydrogenchloride; lithium thiophosphate powder In water for 0.333333h; Ambient temperature; | 94% |
5-nitrobarbituric acid
Thiotepa
N,N',N''-Tris<β-(5-nitro-3-uracil)ethyl>thiophosphoric acid triamide
Conditions | Yield |
---|---|
In water at 37℃; for 288h; | 74.2% |
Thiotepa
acetoneberberine
N',N'',N'''-Tri-<2-(N-Acetonylberberinyl)ethylamide> of thiophosphoric acid
Conditions | Yield |
---|---|
In methanol for 15h; Heating; | 72.4% |
Thiotepa
7,8-dihydroberberine
N',N'',N'''-Tri-(N-dihydroberberinylethylamide) of thiophosphoric acid
Conditions | Yield |
---|---|
In methanol for 15h; Heating; | 69% |
Thiotepa
uracil
N,N',N''-Tris<β-(3-uracil)ethyl>thiophosphoric acid triamide trisodium salt
Conditions | Yield |
---|---|
With sodium hydroxide at 37℃; for 168h; | 64.7% |
Thiotepa
acetoneberberine
N',N''-Di-<2-N-(Acetonylberberinyl)ethylamide> of aziridinylthiophosphoric acid
Conditions | Yield |
---|---|
In acetone for 3h; Heating; | 59.5% |
Thiotepa
oxyberberine
N',N'',N'''-Tri-(N-hydroxyberberinylethylamide) of thiophosphoric acid
Conditions | Yield |
---|---|
In methanol Heating; | 55% |
Thiotepa
acetoneberberine
N'-<2-(N-Acetonylberberinyl)ethylamide> of diaziridinylthiophosphoric acid
Conditions | Yield |
---|---|
In 1,4-dioxane for 1h; Heating; | 51% |
IUPAC Name:IUPAC: Tris(aziridin-1-yl)-sulfanylidene-λ5-phosphane (52-24-4)
Synonyms: Triaziridinylphosphinesulfide ; Triethylenethiophosphorotriamide ; Tris(1-aziridinyl)-phosphinesulfid;tris(1-aziridinyl)phosphinesulphide ; Tris(ethylenimino)thiophosphate ; Wr-45312 ; Triethylenethiophosphoramide, 98+% ; Tris(aziridinyl)phosphinesulphide
CAS: 52-24-4
MF: C6H12N3PS
MW: 189.22
EINECS: 200-135-7
MS:
Mol File: 52-24-4.mol
Surface Tension: 77.7 dyne/cm
Density: 1.5 g/cm3
Flash Point: 117.2 °C
Enthalpy of Vaporization: 50.83 kJ/mol
Boiling Point: 270.2 °C at 760 mmHg
Vapour Pressure: 0.00695 mmHg at 25°C
Melting point: 54-57 °C
Storage temp: 2-8°C
Appearance: solid
Water Solubility: 19 g/100 mL (25 ºC)
Stability: Stable. Incompatible with strong oxidizing agents.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
bird - wild | LD50 | oral | 5620ug/kg (5.62mg/kg) | | Archives of Environmental Contamination and Toxicology. Vol. 12, Pg. 355, 1983. |
dog | LDLo | intravenous | 760ug/kg (0.76mg/kg) | blood: leukopenia | Cancer Chemotherapy Reports, Part 2. Vol. 2, Pg. 203, 1965. |
man | TDLo | parenteral | 631ug/kg (0.631mg/kg) | peripheral nerve and sensation: paresthesis | Cancer Vol. 38, Pg. 1471, 1976. |
monkey | LDLo | intravenous | 1500ug/kg (1.5mg/kg) | blood: leukopenia | Cancer Chemotherapy Reports, Part 2. Vol. 2, Pg. 203, 1965. |
mouse | LD50 | intramuscular | 11500ug/kg (11.5mg/kg) | | Pharmaceutical Chemistry Journal Vol. 17, Pg. 353, 1983. |
mouse | LD50 | intraperitoneal | 11mg/kg (11mg/kg) | | Fiziologicheski Aktivnye Veshchestva. Physiologically Active Substances. Vol. 22, Pg. 36, 1990. |
mouse | LD50 | intravenous | 14500ug/kg (14.5mg/kg) | | Journal of Antibiotics, Series A. Vol. 13, Pg. 19, 1960. |
mouse | LD50 | oral | 38mg/kg (38mg/kg) | peripheral nerve and sensation: flaccid paralysis without anesthesia (usually neuromuscular blockage) | "Imifos," Giller, S.A., ed., Izd, Riga, USSR, 1968Vol. -, Pg. 129, 1968. |
mouse | LD50 | subcutaneous | 16500ug/kg (16.5mg/kg) | liver: "hepatitis (hepatocellular necrosis), zonal" | Farmakologiya i Toksikologiya Vol. 8, Pg. 73, 1973. |
quail | LD50 | oral | 237mg/kg (237mg/kg) | | Ecotoxicology and Environmental Safety. Vol. 6, Pg. 149, 1982. |
rabbit | LD50 | intravenous | 5500ug/kg (5.5mg/kg) | liver: "hepatitis (hepatocellular necrosis), zonal" | Farmakologiya i Toksikologiya Vol. 8, Pg. 73, 1973. |
rat | LD50 | intraarterial | 8750ug/kg (8.75mg/kg) | | Toxicology and Applied Pharmacology. Vol. 4, Pg. 344, 1962. |
rat | LD50 | intraperitoneal | 8mg/kg (8mg/kg) | | Clinical Proceedings of the Children's Hospital of the District of Columbia. Vol. 18, Pg. 307, 1962. |
rat | LD50 | intravenous | 9400ug/kg (9.4mg/kg) | | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 1, 1958. |
rat | LD50 | oral | 23mg/kg (23mg/kg) | | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967. |
rat | LD50 | subcutaneous | 7800ug/kg (7.8mg/kg) | | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, |
Hazard Codes : T+
Risk Statements: 45-46-28
28: Thiotriethylenephosphoramide (52-24-4) is Very Toxic if swallowed
45: May cause cancer
46: Thiotriethylenephosphoramide (52-24-4) may cause heritable genetic damage
Safety Statements: 53-22-26-36/37/39-45-28
22: Do not breathe dust
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
28: After contact with skin, wash immediately with plenty of ... (to be specified by the manufacturer)
45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
53: Avoid exposure - obtain special instruction before use
36/37/39: Wear suitable protective clothing, gloves and eye/face protection
RIDADR: UN 2811 6.1/PG 2
WGK Germany: 3
RTECS: SZ2975000
HazardClass: 6.1(a)
PackingGroup: II
1.Chemical Properties:Thiotriethylenephosphoramide (52-24-4) is white crystals or powder
2.General Description: Odorless white crystalline solid.
3.Air & Water Reactions :Water soluble.
4.Reactivity Profile :Triethylenethiophosphoramide polymerizes readily upon exposure to heat or moisture, especially at acidic pH.
5.Fire Hazard :Flash point data for Triethylenethiophosphoramide are not available. 6.Triethylenethiophosphoramide is probably combustible.